Global Brain Mapping Instruments Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Computed Axial Tomography (CAT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magnetoencephalography, Functional Near-Infrared Spectroscopy (fNIRS), Functional Magnetic Resonance Imaging (fMRI), and Others.

By End User;

Hospitals, Diagnostic Centers, and Other End Users.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn550267855 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Brain Mapping Instruments Market (USD Million), 2021 - 2031

In the year 2024, the Global Brain Mapping Instruments Market was valued at USD 2,416.92 million. The size of this market is expected to increase to USD 4,250.77 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.4%.

With advancements in technology and an increasing understanding of the complexities of the human brain, there has been a surge in demand for sophisticated brain mapping instruments capable of providing detailed insights into brain structure, function, and connectivity. These instruments encompass a diverse range of technologies, including magnetic resonance imaging (MRI), electroencephalography (EEG), magnetoencephalography (MEG), positron emission tomography (PET), and functional near-infrared spectroscopy (fNIRS), among others. As researchers and healthcare practitioners strive to unravel the mysteries of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and epilepsy, the need for precise and accurate brain mapping tools continues to drive innovation and investment in this dynamic market.

In addition to fueling advancements in neuroscience research, the Global Brain Mapping Instruments Market is also witnessing significant growth in clinical applications, particularly in the diagnosis and treatment planning of neurological conditions. Brain mapping techniques play a crucial role in identifying abnormal brain activity, monitoring disease progression, and evaluating the efficacy of therapeutic interventions. The integration of artificial intelligence (AI) and machine learning algorithms with brain mapping instruments holds promise for enhancing diagnostic accuracy and personalizing treatment approaches. With an aging global population and the increasing prevalence of neurological disorders, the demand for brain mapping instruments is expected to escalate further, presenting lucrative opportunities for market players to develop innovative solutions that address the evolving needs of researchers, clinicians, and patients alike.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
  4. Global Brain Mapping Instruments Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. AI integration in brain mapping
        2. Early brain disorder diagnosis need
        3. Non-invasive mapping technique adoption
        4. Brain mapping applications diversification
      2. Restraints
        1. New tech resistance
        2. Mapping accuracy technical limitations
        3. Data interpretation reliability concerns
      3. Opportunities
        1. Neurological disorder intervention
        2. Non-medical field research growth
        3. Neuropharmaceutical trial utilization
        4. Advanced software for analysis
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Brain Mapping Instruments Market, By Product, 2021 - 2031 (USD Million)
      1. Computed Axial Tomography (CAT)
      2. Positron Emission Tomography (PET)
      3. Electroencephalography (EEG)
      4. Magnetoencephalography
      5. Functional Near-Infrared Spectroscopy (fNIRS)
      6. Functional Magnetic Resonance Imaging (fMRI)
      7. Others
    2. Global Brain Mapping Instruments Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Diagnostic Centers
      3. Other End Users
    3. Global Brain Mapping Instruments Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. Medtronic.
      2. General Electric Company
      3. Koninklijke Philips N.V.
      4. Siemens Healthcare Private Limited
      5. Advanced Brain Monitoring, Inc
  7. Analyst Views
  8. Future Outlook of the Market